CFCM Daily Radar — Galectin-9, AI-Designed CAR-T and Immune Monitoring

Paper of the Day — Monocyte Galectin-9 and early AML relapse after haploidentical transplant

Peer-reviewed original research

Weiqian Dai, Xueying Zhao, Linjie Wu, Aiming Pang and colleagues. Monocyte Galectin-9 is associated with CD8⁺ T-cell dysfunction and early relapse after haploidentical hematopoietic stem cell transplantation. Biomarker Research. Published 7 October 2026. DOI: 10.1186/s40364-026-01010-1.

The study examined immune reconstitution after haploidentical transplantation in AML. Increased monocyte surface Galectin-9 was observed in patients who later relapsed, including early post-transplant measurements. The investigators also reported CD8⁺ T-cell dysfunction-associated phenotypes and partial functional restoration after TIM-3 pathway inhibition in experimental systems.

Why it matters to CFCM: flow cytometry may provide clinically relevant information about the immune environment as well as residual leukaemia. However, Galectin-9 remains investigational: the study does not establish a validated clinical threshold or prospective relapse-prediction assay.

Technology Radar — 12,000 AI-designed CAR-T binders put through biological testing

Peer-reviewed original experimental research

Clayton W. Kosonocky, Alex M. Abel, Aaron L. Feller and colleagues. Validation and analysis of 12,000 AI-driven CAR-T designs in the Bits to Binders competition. Molecular Systems Biology. Published 8 October 2026. DOI: 10.1038/s44320-026-00246-1.

The study experimentally screened 12,000 computationally designed CD20-binding minibinders. Hundreds produced significant CD20-dependent proliferation, but only a subset of leading candidates demonstrated strong target-cell killing when individually tested.

Why it matters to CFCM: computational plausibility, binding, proliferation and cytotoxicity are distinct endpoints. The study is a useful model for how AI-generated biological designs require experimental validation rather than headline model performance alone.

Clinical reference populations — Age remodels normal immune phenotypes

Peer-reviewed original research

Age-associated remodeling of NK cell subsets, B cell subsets, and T cell surface markers in peripheral blood of healthy Chinese adults: a prospective multicolor flow cytometry study. Frontiers in Aging. Published 9 October 2026. DOI: 10.3389/fragi.2026.1847033.

The study of 146 healthy adults identified age-associated shifts in T-, B- and NK-cell phenotypes, including increasing CD57 expression and changes in NK subsets. These findings reinforce that reference populations are not biologically static.

CFCM placement: Academy → Reference Intervals and Immunophenotyping; Resources → Clinical Reference Studies.

Transplantation — Pre-transplant marrow lymphocyte subsets and outcome

Peer-reviewed retrospective clinical study

Pre-transplant bone marrow lymphocyte subsets predict outcome after allogeneic stem cell transplantation. Frontiers in Immunology. Published 2 October 2026. DOI: 10.3389/fimmu.2026.1910059.

In 140 adults, pre-transplant lymphocyte distributions were associated with outcomes including CMV infection and graft-versus-host disease. These associations are hypothesis-generating and require external validation before clinical thresholds are adopted.

CFCM placement: News → Transplantation; Academy → Clinical Immunophenotyping.

Editorial decision

Galectin-9 is the featured scientific item because it connects clinical flow cytometry, immune dysfunction and AML relapse. The AI-designed CAR-T study is the strongest Technology Radar item. Age-dependent immunophenotypes and pre-transplant lymphocyte subsets belong primarily in Academy and clinical education.

Evidence note

Galectin-9 is presented as an investigational biomarker, not a validated clinical predictor. AI-designed CAR-T candidates are discussed as experimental designs requiring functional validation, not as clinical products.